SCHEMBL5219019

SCHEMBL5219019

CC(C)(Cc1cccc(Cl)c1)NC[C@@H](O)[C@H](Cc1ccccc1)N(C(=O)O)C(C)(C)C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 5/20 0.41
SLC2A1 P11166 1/20 0.40
RIPK1 Q13546 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRD1 P41143 1/20 0.38
OPRK1 P41145 1/20 0.38
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
ADRB2 P07550 4/20 0.38
ADRB3 P13945 1/20 0.38
PTGES O14684 1/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
KIF11 P52732 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5219027 1.00 CASR (0.41) CASRSLC2A1RIPK1OPRM1OPRD1
SCHEMBL5219515 0.87 SLC2A1 (0.46) SLC2A1ADRB3MEN1ALDH1A1HPGD
SCHEMBL5219507 0.87 SLC2A1 (0.46) SLC2A1ADRB3MEN1ALDH1A1HPGD
SCHEMBL5223457 0.86 CASR (0.46) CASRADRB2CTSD
SCHEMBL5223460 0.86 CASR (0.46) CASRADRB2CTSD
SCHEMBL5930323 0.85 SLC6A2 (0.43) SLC2A1RIPK1SLC6A2SLC6A4LMNA
SCHEMBL5930327 0.85 SLC6A2 (0.43) SLC2A1RIPK1SLC6A2SLC6A4LMNA
SCHEMBL5223492 0.83 OPRM1 (0.40) CASRRIPK1OPRM1OPRD1OPRK1
SCHEMBL5223500 0.83 OPRM1 (0.40) CASRRIPK1OPRM1OPRD1OPRK1
SCHEMBL5218395 0.81 SLC2A1 (0.37) SLC2A1RIPK1PTGESLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567488-B1 HYDROXYETHYLAMINE DERIVATIVES FOR THE TREATMENT OF ALZHEIMER'S DISEASE GLAXO GROUP LTD (GB) 2007-02-21 EP disclosed